Home Alzheimer's Genes AD risk factors Bipolar Genes BP risk factors Autism risk factors.Schizophrenia Genes SZ Risk factors Anorexia genes and risk factors .Chronic Fatigue Risk Factors. Multiple sclerosis risk factors . Parkinson's disease genes and risk factors Cystic Fibrosis Herpes simplex database Jobs in genetics and bioinformatics Pathogens Pathways Useful links Videos . Subscribe to Site Updates by Email  Subscribe in a reader .

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.

These maps, etched out by numerous Autism susceptibility gene candidates from the Autism gene database from Mindspec, literature survey and GWAS studies from Genome.gov are generated by Kegg pathways from the Kanehisa laboratories with thanks and are subject to their copyright conditions: Genes are enhanced by Click on "show all objects" for genes within figures

Pathway Search Result

hsa01100 Metabolic pathways - Homo sapiens (human) (31)

hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]
hsa:10690 FUT9, Fuc-TIX; fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (EC:2.4.1.152); K03663 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase [EC:2.4.1.152]
hsa:114805 GALNT13, FLJ16031, FLJ41157, GalNAc-T13, H_NH0187G20.1, KIAA1918, MGC119459, MGC119461, WUGSC:H_NH0187G20.1; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) (EC:2.4.1.41); K00710 polypeptide N-acetylgalactosaminyltransferase [EC:2.4.1.41]
hsa:121278 TPH2, ADHD7, FLJ37295, MGC138871, MGC138872, NTPH; tryptophan hydroxylase 2 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]
hsa:158 ADSL, AMPS, ASASE, ASL; adenylosuccinate lyase (EC:4.3.2.2); K01756 adenylosuccinate lyase [EC:4.3.2.2]
hsa:1584 CYP11B1, CPN1, CYP11B, DKFZp686B05283, FHI, FLJ36771, P450C11; cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4); K00497 cytochrome P450, family 11, subfamily B1 (steroid 11beta-monooxygenase) [EC:1.14.15.4]
hsa:1608 DGKG, DAGK3, DGK-GAMMA, MGC104993, MGC133330; diacylglycerol kinase, gamma 90kDa (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:1717 DHCR7, SLOS; 7-dehydrocholesterol reductase (EC:1.3.1.21); K00213 7-dehydrocholesterol reductase [EC:1.3.1.21]
hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]
hsa:1806 DPYD, DHP, DHPDHASE, DPD, MGC132008, MGC70799; dihydropyrimidine dehydrogenase (EC:1.3.1.2); K00207 dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:3290 HSD11B1, 11-DH, 11-beta-HSD1, HDL, HSD11, HSD11B, HSD11L, MGC13539, SDR26C1; hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146); K00071 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146]
hsa:3628 INPP1, MGC110984; inositol polyphosphate-1-phosphatase (EC:3.1.3.57); K01107 inositol polyphosphate 1-phosphatase [EC:3.1.3.57]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:438 ASMT, ASMTY, HIOMT, HIOMTY; acetylserotonin O-methyltransferase (EC:2.1.1.4); K00543 acetylserotonin N-methyltransferase [EC:2.1.1.4]
hsa:445 ASS1, ASS, CTLN1; argininosuccinate synthase 1 (EC:6.3.4.5); K01940 argininosuccinate synthase [EC:6.3.4.5]
hsa:4522 MTHFD1, MTHFC, MTHFD; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9); K00288 methylenetetrahydrofolate dehydrogenase (NADP+) / methenyltetrahydrofolate cyclohydrolase / formyltetrahydrofolate synthetase [EC:1.5.1.5 3.5.4.9 6.3.4.3]
hsa:4698 NDUFA5, B13, CI-13KD-B, CI-13kB, DKFZp781K1356, FLJ12147, NUFM, UQOR13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3); K03949 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.5.3 1.6.99.3]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5297 PI4KA, FLJ16556, PI4K-ALPHA, PIK4CA, pi4K230; phosphatidylinositol 4-kinase, catalytic, alpha (EC:2.7.1.67); K00888 phosphatidylinositol 4-kinase [EC:2.7.1.67]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5444 PON1, ESA, MVCD5, PON; paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81); K01045 arylesterase / paraoxonase [EC:3.1.1.2 3.1.8.1]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:6999 TDO2, TDO, TPH2, TRPO; tryptophan 2,3-dioxygenase (EC:1.13.11.11); K00453 tryptophan 2,3-dioxygenase [EC:1.13.11.11]
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]
hsa:7915 ALDH5A1, SSADH, SSDH; aldehyde dehydrogenase 5 family, member A1 (EC:1.2.1.24); K00139 succinate-semialdehyde dehydrogenase [EC:1.2.1.24]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:875 CBS, HIP4; cystathionine-beta-synthase (EC:4.2.1.22); K01697 cystathionine beta-synthase [EC:4.2.1.22]
hsa:8801 SUCLG2, GBETA; succinate-CoA ligase, GDP-forming, beta subunit (EC:6.2.1.4); K01900 succinyl-CoA synthetase beta subunit [EC:6.2.1.4 6.2.1.5]
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (22)



hsa:1268 CNR1, CANN6, CB-R, CB1, CB1A, CB1K5, CB1R, CNR; cannabinoid receptor 1 (brain); K04277 cannabinoid receptor 1
hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:154 ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR; adrenergic, beta-2-, receptor, surface; K04142 adrenergic receptor beta-2
hsa:1814 DRD3, D3DR, ETM1, FET1, MGC149204, MGC149205; dopamine receptor D3; K04146 dopamine receptor D3
hsa:186 AGTR2, AT2, ATGR2, MRX88; angiotensin II receptor, type 2; K04167 angiotensin II receptor type 2
hsa:2557 GABRA4; gamma-aminobutyric acid (GABA) A receptor, alpha 4; K05178 gamma-aminobutyric acid (GABA) A receptor alpha-4
hsa:2560 GABRB1; gamma-aminobutyric acid (GABA) A receptor, beta 1; K05181 gamma-aminobutyric acid (GABA) A receptor beta-1
hsa:2562 GABRB3, ECA5, MGC9051; gamma-aminobutyric acid (GABA) A receptor, beta 3; K05183 gamma-aminobutyric acid (GABA) A receptor beta-3
hsa:2742 GLRA2, GLR; glycine receptor, alpha 2; K05194 glycine receptor alpha-2
hsa:2898 GRIK2, EAA4, GLR6, GLUK6, GLUR6, MGC74427, MRT6; glutamate receptor, ionotropic, kainate 2; K05202 glutamate receptor, ionotropic, kainate 2
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2918 GRM8, FLJ41058, GLUR8, GPRC1H, MGC126724, MGLUR8, mGlu8; glutamate receptor, metabotropic 8; K04608 metabotropic glutamate receptor 6/7/8
hsa:2925 GRPR; gastrin-releasing peptide receptor; K04169 gastrin-releasing peptide receptor
hsa:3351 HTR1B, 5-HT1B, 5-HT1DB, HTR1D2, HTR1DB, S12; 5-hydroxytryptamine (serotonin) receptor 1B; K04153 5-hydroxytryptamine receptor 1
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:3363 HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled); K04163 5-hydroxytryptamine receptor 7
hsa:3953 LEPR, CD295, DKFZp686B1731, OBR; leptin receptor; K05062 leptin receptor
hsa:4988 OPRM1, KIAA0403, LMOR, MOR, MOR1, OPRM; opioid receptor, mu 1; K04215 opioid receptor mu 1
hsa:5021 OXTR, OT-R; oxytocin receptor; K04229 oxytocin receptor
hsa:552 AVPR1A, AVPR1; arginine vasopressin receptor 1A; K04226 arginine vasopressin receptor 1A
hsa:56288 PARD3, ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2; par-3 partitioning defective 3 homolog (C. elegans); K04237 partitioning defective protein 3
hsa:9248 GPR50, H9, MGC125342, Mel1c; G protein-coupled receptor 50; K04287 G protein-coupled receptor 50

hsa04020 Calcium signaling pathway - Homo sapiens (human) (22)



hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:154 ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR; adrenergic, beta-2-, receptor, surface; K04142 adrenergic receptor beta-2
hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:2925 GRPR; gastrin-releasing peptide receptor; K04169 gastrin-releasing peptide receptor
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:3363 HTR7, 5-HT7; 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled); K04163 5-hydroxytryptamine receptor 7
hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5021 OXTR, OT-R; oxytocin receptor; K04229 oxytocin receptor
hsa:5350 PLN, CMD1P, PLB; phospholamban; K05852 phospholamban
hsa:552 AVPR1A, AVPR1; arginine vasopressin receptor 1A; K04226 arginine vasopressin receptor 1A
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F
hsa:8911 CACNA1I, Cav3.3, KIAA1120; calcium channel, voltage-dependent, T type, alpha 1I subunit; K04856 voltage-dependent calcium channel T type alpha-1I
hsa:8912 CACNA1H, CACNA1HB, Cav3.2, ECA6, EIG6, FLJ90484; calcium channel, voltage-dependent, T type, alpha 1H subunit; K04855 voltage-dependent calcium channel T type alpha-1H
hsa:8913 CACNA1G, Ca(V)T.1, Cav3.1, MGC117234, NBR13; calcium channel, voltage-dependent, T type, alpha 1G subunit; K04854 voltage-dependent calcium channel T type alpha-1G
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04010 MAPK signaling pathway - Homo sapiens (human) (21)



hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
hsa:2263 FGFR2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]
hsa:23542 MAPK8IP2, IB2, JIP2, PRKM8IPL; mitogen-activated protein kinase 8 interacting protein 2; K04435 mitogen-activated protein kinase 8 interacting protein 2
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4208 MEF2C, C5DELq14.3;_DEL5q14.3; myocyte enhancer factor 2C; K04454 MADS-box transcription enhancer factor 2C
hsa:4214 MAP3K1, MAPKKK1, MEKK, MEKK1; mitogen-activated protein kinase kinase kinase 1 (EC:2.7.11.25); K04416 mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
hsa:4763 NF1, DKFZp686J1293, FLJ21220, NFNS, VRNF, WSS; neurofibromin 1; K08052 neurofibromin 1
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8911 CACNA1I, Cav3.3, KIAA1120; calcium channel, voltage-dependent, T type, alpha 1I subunit; K04856 voltage-dependent calcium channel T type alpha-1I
hsa:8912 CACNA1H, CACNA1HB, Cav3.2, ECA6, EIG6, FLJ90484; calcium channel, voltage-dependent, T type, alpha 1H subunit; K04855 voltage-dependent calcium channel T type alpha-1H
hsa:8913 CACNA1G, Ca(V)T.1, Cav3.1, MGC117234, NBR13; calcium channel, voltage-dependent, T type, alpha 1G subunit; K04854 voltage-dependent calcium channel T type alpha-1G

hsa05200 Pathways in cancer - Homo sapiens (human) (20)



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1612 DAPK1, DAPK, DKFZp781I035; death-associated protein kinase 1 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1]
hsa:2263 FGFR2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:367 AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:7472 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2
hsa:9915 ARNT2, KIAA0307, bHLHe1; aryl-hydrocarbon receptor nuclear translocator 2; K09097 hypoxia-inducible factor 1 beta

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (19)



hsa:1000 CDH2, CD325, CDHN, CDw325, NCAD; cadherin 2, type 1, N-cadherin (neuronal); K06736 cadherin 2, type 1, N-cadherin
hsa:1002 CDH4, CAD4, FLJ22202, FLJ40547, MGC126700, MGC138355, RCAD; cadherin 4, type 1, R-cadherin (retinal); K06797 cadherin 4, type 1, R-cadherin
hsa:214 ALCAM, CD166, FLJ38514, MEMD, MGC71733; activated leukocyte cell adhesion molecule; K06547 activated leukocyte cell adhesion molecule
hsa:22871 NLGN1, KIAA1070, MGC45115, NL1; neuroligin 1; K07378 neuroligin
hsa:23705 CADM1, BL2, DKFZp686F1789, IGSF4, IGSF4A, MGC149785, MGC51880, NECL2, Necl-2, RA175, ST17, SYNCAM, TSLC1, sTSLC-1, sgIGSF, synCAM1; cell adhesion molecule 1; K06781 immunoglobulin superfamily, member 4
hsa:26047 CNTNAP2, AUTS15, CASPR2, CDFE, DKFZp781D1846, NRXN4, PTHSL1; contactin associated protein-like 2; K07380 contactin associated protein-like 2
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:4685 NCAM2, MGC51008, NCAM21; neural cell adhesion molecule 2; K06491 neural cell adhesion molecule
hsa:4897 NRCAM, KIAA0343, MGC138845, MGC138846; neuronal cell adhesion molecule; K06756 neuronal cell adhesion molecule
hsa:54413 NLGN3, HNL3, KIAA1480; neuroligin 3; K07378 neuroligin
hsa:57502 NLGN4X, ASPGX2, AUTSX2, HLNX, HNLX, KIAA1260, MGC22376, NLGN, NLGN4; neuroligin 4, X-linked; K07378 neuroligin
hsa:5797 PTPRM, MGC166994, PTPRL1, R-PTP-MU, RPTPM, RPTPU, hR-PTPu; protein tyrosine phosphatase, receptor type, M (EC:3.1.3.48); K05693 protein tyrosine phosphatase, receptor type, M [EC:3.1.3.48]
hsa:5818 PVRL1, CD111, CLPED1, ED4, HIgR, HVEC, MGC142031, MGC16207, OFC7, PRR, PRR1, PVRR, PVRR1, SK-12, nectin-1; poliovirus receptor-related 1 (herpesvirus entry mediator C); K06081 poliovirus receptor-related protein 1
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:9378 NRXN1, DKFZp313P2036, FLJ35941, Hs.22998, KIAA0578, PTHSL2; neurexin 1; K07377 neurexin

hsa04510 Focal adhesion - Homo sapiens (human) (19)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1793 DOCK1, DOCK180, ced5; dedicator of cytokinesis 1; K13708 dedicator of cytokinesis 1
hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:55742 PARVA, CH-ILKBP, FLJ10793, FLJ12254, FLJ25106, FLJ46049, MXRA2; parvin, alpha; K06275 parvin
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (15)



hsa:10458 BAIAP2, BAP2, FLAF3, IRSP53; BAI1-associated protein 2; K05627 BAI1-associated protein 2
hsa:10788 IQGAP2; IQ motif containing GTPase activating protein 2; K05767 IQ motif containing GTPase activating protein
hsa:1793 DOCK1, DOCK180, ced5; dedicator of cytokinesis 1; K13708 dedicator of cytokinesis 1
hsa:2263 FGFR2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]
hsa:23191 CYFIP1, FLJ45151, P140SRA-1, SHYC, SRA1; cytoplasmic FMR1 interacting protein 1; K05749 cytoplasmic FMR1 interacting protein
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:81624 DIAPH3, DKFZp434C0931, DKFZp686A13178, DRF3, FLJ34705, diap3, mDia2; diaphanous homolog 3 (Drosophila); K05745 diaphanous 3

hsa04360 Axon guidance - Homo sapiens (human) (15)



hsa:10154 PLXNC1, CD232, PLXN-C1, VESPR; plexin C1; K06572 plexin C
hsa:10507 SEMA4D, C9orf164, CD100, FLJ33485, FLJ34282, FLJ39737, FLJ46484, M-sema-G, MGC169138, MGC169141, SEMAJ, coll-4; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D; K06521 semaphorin 4
hsa:137970 UNC5D, FLJ16019, KIAA1777, PRO34692, Unc5h4; unc-5 homolog D (C. elegans); K07521 netrin receptor unc-5
hsa:22854 NTNG1, KIAA0976, Lmnt1; netrin G1; K07522 netrin G1
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:57556 SEMA6A, HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ, VIA; sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A; K06842 semaphorin 6
hsa:6091 ROBO1, DUTT1, FLJ21882, MGC131599, MGC133277, SAX3; roundabout, axon guidance receptor, homolog 1 (Drosophila); K06753 roundabout, axon guidance receptor 1
hsa:6092 ROBO2, KIAA1568, SAX3; roundabout, axon guidance receptor, homolog 2 (Drosophila); K06754 roundabout, axon guidance receptor 2
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:8440 NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein
hsa:9037 SEMA5A, FLJ12815, SEMAF, semF; sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A; K06841 semaphorin 5
hsa:9901 SRGAP3, ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP; SLIT-ROBO Rho GTPase activating protein 3; K07526 SLIT-ROBO Rho GTPase activating protein

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (13)



hsa:1000 CDH2, CD325, CDHN, CDw325, NCAD; cadherin 2, type 1, N-cadherin (neuronal); K06736 cadherin 2, type 1, N-cadherin
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F

hsa04520 Adherens junction - Homo sapiens (human) (13)



hsa:10458 BAIAP2, BAP2, FLAF3, IRSP53; BAI1-associated protein 2; K05627 BAI1-associated protein 2
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1500 CTNND1, CAS, CTNND, KIAA0384, P120CAS, P120CTN, p120, p120(CAS), p120(CTN); catenin (cadherin-associated protein), delta 1; K05690 catenin (cadherin-associated protein), delta 1
hsa:2241 FER, TYK3; fer (fps/fes related) tyrosine kinase (EC:2.7.10.2); K08889 fer (fps/fes related) tyrosine kinase [EC:2.7.10.2]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:56288 PARD3, ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2; par-3 partitioning defective 3 homolog (C. elegans); K04237 partitioning defective protein 3
hsa:5770 PTPN1, PTP1B; protein tyrosine phosphatase, non-receptor type 1 (EC:3.1.3.48); K05696 protein tyrosine phosphatase, non-receptor type 1 [EC:3.1.3.48]
hsa:5797 PTPRM, MGC166994, PTPRL1, R-PTP-MU, RPTPM, RPTPU, hR-PTPu; protein tyrosine phosphatase, receptor type, M (EC:3.1.3.48); K05693 protein tyrosine phosphatase, receptor type, M [EC:3.1.3.48]
hsa:5818 PVRL1, CD111, CLPED1, ED4, HIgR, HVEC, MGC142031, MGC16207, OFC7, PRR, PRR1, PVRR, PVRR1, SK-12, nectin-1; poliovirus receptor-related 1 (herpesvirus entry mediator C); K06081 poliovirus receptor-related protein 1
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (13)



hsa:135 ADORA2A, ADORA2, RDC8, hA2aR; adenosine A2a receptor; K04266 adenosine receptor A2a
hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:552 AVPR1A, AVPR1; arginine vasopressin receptor 1A; K04226 arginine vasopressin receptor 1A
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F
hsa:800 CALD1, CDM, H-CAD, HCAD, L-CAD, LCAD, MGC21352, NAG22; caldesmon 1; K12327 caldesmon
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04144 Endocytosis - Homo sapiens (human) (12)



hsa:116987 AGAP1, CENTG2, GGAP1, KIAA1099, MGC71657; ArfGAP with GTPase domain, ankyrin repeat and PH domain 1; K12491 Arf-GAP, GTPase, ANK repeat and PH domain-containing protein 1/2/3
hsa:154 ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR; adrenergic, beta-2-, receptor, surface; K04142 adrenergic receptor beta-2
hsa:2263 FGFR2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]
hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:30011 SH3KBP1, CD2BP3, CIN85, GIG10, HSB-1, HSB1, MIG18; SH3-domain kinase binding protein 1; K12470 SH3 domain-containing kinase-binding protein 1
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
hsa:56288 PARD3, ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2; par-3 partitioning defective 3 homolog (C. elegans); K04237 partitioning defective protein 3
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:84552 PARD6G, FLJ45701, PAR-6G, PAR6gamma; par-6 partitioning defective 6 homolog gamma (C. elegans); K06093 partitioning defective protein 6

hsa04530 Tight junction - Homo sapiens (human) (12)



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:56288 PARD3, ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2; par-3 partitioning defective 3 homolog (C. elegans); K04237 partitioning defective protein 3
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:84552 PARD6G, FLJ45701, PAR-6G, PAR6gamma; par-6 partitioning defective 6 homolog gamma (C. elegans); K06093 partitioning defective protein 6
hsa:9223 MAGI1, AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3; membrane associated guanylate kinase, WW and PDZ domain containing 1; K05631 atrophin-1 interacting protein 3 (BAI1-associated protein 1)
hsa:9863 MAGI2, ACVRIP1, AIP1, ARIP1, MAGI-2, SSCAM; membrane associated guanylate kinase, WW and PDZ domain containing 2; K05629 atrophin-1 interacting protein 1

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (11)



hsa:11069 RAPGEF4, CAMP-GEFII, CGEF2, EPAC2, Nbla00496; Rap guanine nucleotide exchange factor (GEF) 4; K04351 Rap guanine nucleotide exchange factor (GEF) 4
hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1500 CTNND1, CAS, CTNND, KIAA0384, P120CAS, P120CTN, p120, p120(CAS), p120(CTN); catenin (cadherin-associated protein), delta 1; K05690 catenin (cadherin-associated protein), delta 1
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (11)



hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:5350 PLN, CMD1P, PLB; phospholamban; K05852 phospholamban
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F

hsa04912 GnRH signaling pathway - Homo sapiens (human) (10)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4214 MAP3K1, MAPKKK1, MEKK, MEKK1; mitogen-activated protein kinase kinase kinase 1 (EC:2.7.11.25); K04416 mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04512 ECM-receptor interaction - Homo sapiens (human) (9)



hsa:2812 GP1BB, CD42C, GPIBB; glycoprotein Ib (platelet), beta polypeptide; K06262 platelet glycoprotein Ib beta chain
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:5649 RELN, PRO1598, RL; reelin; K06249 reelin [EC:3.4.21.-]
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (9)



hsa:2833 CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR; chemokine (C-X-C motif) receptor 3; K04188 C-X-C chemokine receptor type 3
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:56288 PARD3, ASIP, Baz, Bazooka, FLJ21015, PAR3, PAR3alpha, PARD3A, SE2-5L16, SE2-5LT1, SE2-5T2; par-3 partitioning defective 3 homolog (C. elegans); K04237 partitioning defective protein 3
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:57580 PREX1, KIAA1415, P-REX1; phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1; K12365 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchanger 1 protein
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1

hsa04910 Insulin signaling pathway - Homo sapiens (human) (9)



hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5770 PTPN1, PTP1B; protein tyrosine phosphatase, non-receptor type 1 (EC:3.1.3.48); K05696 protein tyrosine phosphatase, non-receptor type 1 [EC:3.1.3.48]
hsa:7248 TSC1, KIAA0243, LAM, MGC86987, TSC; tuberous sclerosis 1; K07206 tuberous sclerosis 1
hsa:7249 TSC2, FLJ43106, LAM, TSC4; tuberous sclerosis 2; K07207 tuberous sclerosis 2
hsa:8660 IRS2, IRS-2; insulin receptor substrate 2; K07187 insulin receptor substrate
hsa:8835 SOCS2, CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2; suppressor of cytokine signaling 2; K04695 suppressor of cytokine signaling 2

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (9)



hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3680 ITGA9, ALPHA-RLC, ITGA4L, RLC; integrin, alpha 9; K06585 integrin alpha 9
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F

hsa04370 VEGF signaling pathway - Homo sapiens (human) (8)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (8)



hsa:1608 DGKG, DAGK3, DGK-GAMMA, MGC104993, MGC133330; diacylglycerol kinase, gamma 90kDa (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:3628 INPP1, MGC110984; inositol polyphosphate-1-phosphatase (EC:3.1.3.57); K01107 inositol polyphosphate 1-phosphatase [EC:3.1.3.57]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5297 PI4KA, FLJ16556, PI4K-ALPHA, PIK4CA, pi4K230; phosphatidylinositol 4-kinase, catalytic, alpha (EC:2.7.1.67); K00888 phosphatidylinositol 4-kinase [EC:2.7.1.67]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (8) Autism and bacteria PUBMED



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:1793 DOCK1, DOCK180, ced5; dedicator of cytokinesis 1; K13708 dedicator of cytokinesis 1
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1

hsa04972 Pancreatic secretion - Homo sapiens (human) (8)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (8)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4214 MAP3K1, MAPKKK1, MEKK, MEKK1; mitogen-activated protein kinase kinase kinase 1 (EC:2.7.11.25); K04416 mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
hsa:4916 NTRK3, TRKC, gp145(trkC); neurotrophic tyrosine kinase, receptor, type 3 (EC:2.7.10.1); K05101 neurotrophic tyrosine kinase, receptor type 3 [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]
hsa:8660 IRS2, IRS-2; insulin receptor substrate 2; K07187 insulin receptor substrate

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (7)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04012 ErbB signaling pathway - Homo sapiens (human) (7)



hsa:10718 NRG3, HRG3, pro-NRG3; neuregulin 3; K05457 neuregulin 3
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]
hsa:8440 NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein

hsa05213 Endometrial cancer - Homo sapiens (human) (7)



hsa:1496 CTNNA2, CAP-R, CAPR, CT114, CTNR, DKFZp686H02198; catenin (cadherin-associated protein), alpha 2; K05691 catenin (cadherin-associated protein), alpha
hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:29119 CTNNA3, MGC26194, MGC75041, VR22; catenin (cadherin-associated protein), alpha 3; K05691 catenin (cadherin-associated protein), alpha
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa05145 Toxoplasmosis - Homo sapiens (human) (7)



hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa05222 Small cell lung cancer - Homo sapiens (human) (7)



hsa:2272 FHIT, AP3Aase, FRA3B; fragile histidine triad gene (EC:3.6.1.29); K01522 bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]

hsa05146 Amoebiasis - Homo sapiens (human) (7)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3912 LAMB1, CLM, MGC142015; laminin, beta 1; K05636 laminin, beta 1
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5747 PTK2, FADK, FAK, FAK1, FRNK, pp125FAK; PTK2 protein tyrosine kinase 2 (EC:2.7.10.2); K05725 PTK2 protein tyrosine kinase 2 [EC:2.7.10.2]

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (6)



hsa:2812 GP1BB, CD42C, GPIBB; glycoprotein Ib (platelet), beta polypeptide; K06262 platelet glycoprotein Ib beta chain
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen

hsa04310 Wnt signaling pathway - Homo sapiens (human) (6)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
hsa:7472 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2

hsa04720 Long-term potentiation - Homo sapiens (human) (6)



hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (6)



hsa:3290 HSD11B1, 11-DH, 11-beta-HSD1, HDL, HSD11, HSD11B, HSD11L, MGC13539, SDR26C1; hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146); K00071 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:6446 SGK1, SGK; serum/glucocorticoid regulated kinase 1 (EC:2.7.11.1); K13302 serum/glucocorticoid-regulated kinase 1 [EC:2.7.11.1]
hsa:8660 IRS2, IRS-2; insulin receptor substrate 2; K07187 insulin receptor substrate

hsa04970 Salivary secretion - Homo sapiens (human) (6)



hsa:154 ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR; adrenergic, beta-2-, receptor, surface; K04142 adrenergic receptor beta-2
hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3778 KCNMA1, BKTM, DKFZp686K1437, KCa1.1, MGC71881, MaxiK, SAKCA, SLO, SLO-ALPHA, SLO1, bA205K10.1, mSLO1; potassium large conductance calcium-activated channel, subfamily M, alpha member 1; K04936 potassium large conductance calcium-activated channel subfamily M alpha member 1
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa05140 Leishmaniasis - Homo sapiens (human) (6)



hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa05215 Prostate cancer - Homo sapiens (human) (6)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2263 FGFR2, BEK, BFR-1, CD332, CEK3, CFD1, ECT1, FLJ98662, JWS, K-SAM, KGFR, TK14, TK25; fibroblast growth factor receptor 2 (EC:2.7.10.1); K05093 fibroblast growth factor receptor 2 [EC:2.7.10.1]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:367 AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa04730 Long-term depression - Homo sapiens (human) (6)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (6)



hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
hsa:8440 NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (6)



hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:8660 IRS2, IRS-2; insulin receptor substrate 2; K07187 insulin receptor substrate
hsa:8835 SOCS2, CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2; suppressor of cytokine signaling 2; K04695 suppressor of cytokine signaling 2
hsa:8913 CACNA1G, Ca(V)T.1, Cav3.1, MGC117234, NBR13; calcium channel, voltage-dependent, T type, alpha 1G subunit; K04854 voltage-dependent calcium channel T type alpha-1G

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (6)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa04916 Melanogenesis - Homo sapiens (human) (6)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:7472 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2

hsa04150 mTOR signaling pathway - Homo sapiens (human) (5)



hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]
hsa:7248 TSC1, KIAA0243, LAM, MGC86987, TSC; tuberous sclerosis 1; K07206 tuberous sclerosis 1
hsa:7249 TSC2, FLJ43106, LAM, TSC4; tuberous sclerosis 2; K07207 tuberous sclerosis 2

hsa04540 Gap junction - Homo sapiens (human) (5)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:3356 HTR2A, 5-HT2A, HTR2; 5-hydroxytryptamine (serotonin) receptor 2A; K04157 5-hydroxytryptamine receptor 2
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (5)



hsa:2272 FHIT, AP3Aase, FRA3B; fragile histidine triad gene (EC:3.6.1.29); K01522 bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (5)



hsa:3628 INPP1, MGC110984; inositol polyphosphate-1-phosphatase (EC:3.1.3.57); K01107 inositol polyphosphate 1-phosphatase [EC:3.1.3.57]
hsa:5287 PIK3C2B, C2-PI3K, DKFZp686G16234; phosphoinositide-3-kinase, class 2, beta polypeptide (EC:2.7.1.154); K00923 phosphatidylinositol-4-phosphate 3-kinase [EC:2.7.1.154]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5297 PI4KA, FLJ16556, PI4K-ALPHA, PIK4CA, pi4K230; phosphatidylinositol 4-kinase, catalytic, alpha (EC:2.7.1.67); K00888 phosphatidylinositol 4-kinase [EC:2.7.1.67]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (5)



hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa00250 Alanine, aspartate and glutamate metabolism - Homo sapiens (human) (5)



hsa:158 ADSL, AMPS, ASASE, ASL; adenylosuccinate lyase (EC:4.3.2.2); K01756 adenylosuccinate lyase [EC:4.3.2.2]
hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:445 ASS1, ASS, CTLN1; argininosuccinate synthase 1 (EC:6.3.4.5); K01940 argininosuccinate synthase [EC:6.3.4.5]
hsa:7915 ALDH5A1, SSADH, SSDH; aldehyde dehydrogenase 5 family, member A1 (EC:1.2.1.24); K00139 succinate-semialdehyde dehydrogenase [EC:1.2.1.24]

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (5)



hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:2833 CXCR3, CD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR; chemokine (C-X-C motif) receptor 3; K04188 C-X-C chemokine receptor type 3
hsa:3953 LEPR, CD295, DKFZp686B1731, OBR; leptin receptor; K05062 leptin receptor
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4

hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human) (5)



hsa:4214 MAP3K1, MAPKKK1, MEKK, MEKK1; mitogen-activated protein kinase kinase kinase 1 (EC:2.7.11.25); K04416 mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
hsa:5071 PARK2, AR-JP, LPRS2, PDJ, PRKN; parkinson protein 2, E3 ubiquitin protein ligase (parkin); K04556 parkin [EC:6.3.2.19]
hsa:64326 RFWD2, COP1, FLJ10416, RNF200; ring finger and WD repeat domain 2; K10143 E3 ubiquitin-protein ligase RFWD2 [EC:6.3.2.19]
hsa:7328 UBE2H, E2-20K, UBC8, UBCH, UBCH2; ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast) (EC:6.3.2.19); K10576 ubiquitin-conjugating enzyme E2 H [EC:6.3.2.19]
hsa:7337 UBE3A, ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A; ubiquitin protein ligase E3A (EC:6.3.2.19); K10587 ubiquitin-protein ligase E3 A [EC:6.3.2.19]

hsa05010 Alzheimer's disease - Homo sapiens (human) (5)



hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:4698 NDUFA5, B13, CI-13KD-B, CI-13kB, DKFZp781K1356, FLJ12147, NUFM, UQOR13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3); K03949 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.5.3 1.6.99.3]
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F

hsa05214 Glioma - Homo sapiens (human) (5)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa05416 Viral myocarditis - Homo sapiens (human) (5)



hsa:1525 CXADR, CAR, CAR4/6, HCAR; coxsackie virus and adenovirus receptor; K06788 coxsackievirus and adenovirus receptor
hsa:1756 DMD, BMD, CMD3B, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272; dystrophin; K10366 dystrophin
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (5)



hsa:10253 SPRY2, MGC23039, hSPRY2; sprouty homolog 2 (Drosophila); K04704 sprouty
hsa:3953 LEPR, CD295, DKFZp686B1731, OBR; leptin receptor; K05062 leptin receptor
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:81848 SPRY4; sprouty homolog 4 (Drosophila); K04704 sprouty
hsa:8835 SOCS2, CIS2, Cish2, SOCS-2, SSI-2, SSI2, STATI2; suppressor of cytokine signaling 2; K04695 suppressor of cytokine signaling 2

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (5)



hsa:10479 SLC9A6, KIAA0267, MRSA, NHE6; solute carrier family 9 (sodium/hydrogen exchanger), member 6; K12041 solute carrier family 9, member 6
hsa:6262 RYR2, ARVC2, ARVD2, VTSIP; ryanodine receptor 2 (cardiac); K04962 ryanodine receptor 2
hsa:775 CACNA1C, CACH2, CACN2, CACNL1A1, CCHL1A1, CaV1.2, MGC120730, TS; calcium channel, voltage-dependent, L type, alpha 1C subunit; K04850 voltage-dependent calcium channel L type alpha-1C
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D
hsa:778 CACNA1F, AIED, COD3, COD4, CORDX, CORDX3, CSNB2, CSNB2A, CSNBX2, Cav1.4, JM8, JMC8, OA2; calcium channel, voltage-dependent, L type, alpha 1F subunit; K04853 voltage-dependent calcium channel L type alpha-1F

hsa00590 Arachidonic acid metabolism - Homo sapiens (human) (4)



hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:5743 PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1); K11987 prostaglandin-endoperoxide synthase 2 [EC:1.14.99.1]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (4)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:8440 NCK2, GRB4, NCKbeta; NCK adaptor protein 2; K07365 NCK adaptor protein

hsa04380 Osteoclast differentiation - Homo sapiens (human) (4)



hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (4)



hsa:2152 F3, CD142, FLJ17960, TF, TFA; coagulation factor III (thromboplastin, tissue factor); K03901 coagulation factor III (tissue factor)
hsa:2162 F13A1, F13A; coagulation factor XIII, A1 polypeptide (EC:2.3.2.13); K03917 coagulation factor XIII A1 polypeptide [EC:2.3.2.13]
hsa:5329 PLAUR, CD87, U-PAR, UPAR, URKR; plasminogen activator, urokinase receptor; K03985 plasminogen activator, urokinase receptor
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4

hsa05012 Parkinson's disease - Homo sapiens (human) (4)



hsa:4698 NDUFA5, B13, CI-13KD-B, CI-13kB, DKFZp781K1356, FLJ12147, NUFM, UQOR13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3); K03949 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.5.3 1.6.99.3]
hsa:5071 PARK2, AR-JP, LPRS2, PDJ, PRKN; parkinson protein 2, E3 ubiquitin protein ligase (parkin); K04556 parkin [EC:6.3.2.19]
hsa:5413 SEPT5, CDCREL, CDCREL-1, CDCREL1, H5, HCDCREL-1, PNUTL1; septin 5 (EC:3.1.5.1); K04557 peanut-like protein 1 (cell division control related protein 1)
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa05211 Renal cell carcinoma - Homo sapiens (human) (4)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:9915 ARNT2, KIAA0307, bHLHe1; aryl-hydrocarbon receptor nuclear translocator 2; K09097 hypoxia-inducible factor 1 beta

hsa05218 Melanoma - Homo sapiens (human) (4)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]

hsa00230 Purine metabolism - Homo sapiens (human) (4)



hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]
hsa:158 ADSL, AMPS, ASASE, ASL; adenylosuccinate lyase (EC:4.3.2.2); K01756 adenylosuccinate lyase [EC:4.3.2.2]
hsa:2272 FHIT, AP3Aase, FRA3B; fragile histidine triad gene (EC:3.6.1.29); K01522 bis(5'-adenosyl)-triphosphatase [EC:3.6.1.29]
hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]

hsa00380 Tryptophan metabolism - Homo sapiens (human) (4)



hsa:121278 TPH2, ADHD7, FLJ37295, MGC138871, MGC138872, NTPH; tryptophan hydroxylase 2 (EC:1.14.16.4); K00502 tryptophan 5-monooxygenase [EC:1.14.16.4]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:438 ASMT, ASMTY, HIOMT, HIOMTY; acetylserotonin O-methyltransferase (EC:2.1.1.4); K00543 acetylserotonin N-methyltransferase [EC:2.1.1.4]
hsa:6999 TDO2, TDO, TPH2, TRPO; tryptophan 2,3-dioxygenase (EC:1.13.11.11); K00453 tryptophan 2,3-dioxygenase [EC:1.13.11.11]

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (4)



hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3676 ITGA4, CD49D, IA4, MGC90518; integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor); K06483 integrin alpha 4
hsa:3695 ITGB7; integrin, beta 7; K06590 integrin beta 7
hsa:7852 CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM; chemokine (C-X-C motif) receptor 4; K04189 C-X-C chemokine receptor type 4

hsa04971 Gastric acid secretion - Homo sapiens (human) (4)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:4638 MYLK, DKFZp686I10125, FLJ12216, KRP, MLCK, MLCK1, MLCK108, MLCK210, MSTP083, MYLK1, smMLCK; myosin light chain kinase (EC:2.7.11.18 2.7.1.117); K00907 myosin-light-chain kinase [EC:2.7.11.18]
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05142 Chagas disease (American trypanosomiasis) - Homo sapiens (human) (4)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B

hsa05110 Vibrio cholerae infection - Homo sapiens (human) (3)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05210 Colorectal cancer - Homo sapiens (human) (3)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04973 Carbohydrate digestion and absorption - Homo sapiens (human) (3)



hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:776 CACNA1D, CACH3, CACN4, CACNL1A2, CCHL1A2, Cav1.3; calcium channel, voltage-dependent, L type, alpha 1D subunit; K04851 voltage-dependent calcium channel L type alpha-1D

hsa00650 Butanoate metabolism - Homo sapiens (human) (3)



hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:7915 ALDH5A1, SSADH, SSDH; aldehyde dehydrogenase 5 family, member A1 (EC:1.2.1.24); K00139 succinate-semialdehyde dehydrogenase [EC:1.2.1.24]

hsa00330 Arginine and proline metabolism - Homo sapiens (human) (3)



hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:445 ASS1, ASS, CTLN1; argininosuccinate synthase 1 (EC:6.3.4.5); K01940 argininosuccinate synthase [EC:6.3.4.5]
hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]

hsa04210 Apoptosis - Homo sapiens (human) (3)



hsa:4803 NGF, Beta-NGF, HSAN5, MGC161426, MGC161428, NGFB; nerve growth factor (beta polypeptide); K02582 nerve growth factor, beta
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa05131 Shigellosis - Homo sapiens (human) (3)



hsa:1793 DOCK1, DOCK180, ced5; dedicator of cytokinesis 1; K13708 dedicator of cytokinesis 1
hsa:960 CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MGC10468, MIC4, Pgp1; CD44 molecule (Indian blood group); K06256 CD44 antigen
hsa:9844 ELMO1, CED-12, CED12, ELMO-1, KIAA0281, MGC126406; engulfment and cell motility 1; K12366 engulfment and cell motility protein 1

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (3)



hsa:1608 DGKG, DAGK3, DGK-GAMMA, MGC104993, MGC133330; diacylglycerol kinase, gamma 90kDa (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]
hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa05216 Thyroid cancer - Homo sapiens (human) (3)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:4914 NTRK1, DKFZp781I14186, MTC, TRK, TRK1, TRKA, Trk-A, p140-TrkA; neurotrophic tyrosine kinase, receptor, type 1 (EC:2.7.10.1); K03176 neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]

hsa04914 Progesterone-mediated oocyte maturation - Homo sapiens (human) (3)



hsa:5139 PDE3A, CGI-PDE; phosphodiesterase 3A, cGMP-inhibited (EC:3.1.4.17); K13296 cGMP-inhibited 3',5'-cyclic phosphodiesterase [EC:3.1.4.17]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (3)



hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]
hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa04710 Circadian rhythm - mammal - Homo sapiens (human) (3)



hsa:4862 NPAS2, FLJ23138, MGC71151, MOP4, PASD4, bHLHe9; neuronal PAS domain protein 2; K09026 neuronal PAS domain-containing protein 2
hsa:5187 PER1, MGC88021, PER, RIGUI, hPER; period homolog 1 (Drosophila); K02633 period circadian protein
hsa:6095 RORA, DKFZp686M2414, MGC119326, MGC119329, NR1F1, ROR1, ROR2, ROR3, RZR-ALPHA, RZRA; RAR-related orphan receptor A; K08532 RAR-related orphan receptor alpha

hsa05016 Huntington's disease - Homo sapiens (human) (3)



hsa:1742 DLG4, FLJ97752, FLJ98574, PSD95, SAP-90, SAP90; discs, large homolog 4 (Drosophila); K11828 discs large protein 4
hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:4698 NDUFA5, B13, CI-13KD-B, CI-13kB, DKFZp781K1356, FLJ12147, NUFM, UQOR13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3); K03949 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.5.3 1.6.99.3]

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (3)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (3)



hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (3)



hsa:1326 MAP3K8, COT, EST, ESTF, FLJ10486, MEKK8, TPL2, Tpl-2, c-COT; mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25); K04415 mitogen-activated protein kinase kinase kinase 8 [EC:2.7.11.25]
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa05217 Basal cell carcinoma - Homo sapiens (human) (3)



hsa:1499 CTNNB1, CTNNB, DKFZp686D02253, FLJ25606, FLJ37923; catenin (cadherin-associated protein), beta 1, 88kDa; K02105 catenin (cadherin-associated protein), beta 1
hsa:324 APC, BTPS2, DP2, DP2.5, DP3, GS; adenomatous polyposis coli; K02085 adenomatosis polyposis coli protein
hsa:7472 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2

hsa04145 Phagosome - Homo sapiens (human) (3)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:3690 ITGB3, CD61, GP3A, GPIIIa; integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); K06493 integrin beta 3

hsa00410 beta-Alanine metabolism - Homo sapiens (human) (3)



hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]
hsa:1806 DPYD, DHP, DHPDHASE, DPD, MGC132008, MGC70799; dihydropyrimidine dehydrogenase (EC:1.3.1.2); K00207 dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]
hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa05160 Hepatitis C - Homo sapiens (human) (3)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]
hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B

hsa04115 p53 signaling pathway - Homo sapiens (human) (3)



hsa:5728 PTEN, 10q23del, BZS, DEC, GLM2, MGC11227, MHAM, MMAC1, PTEN1, TEP1; phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48); K01110 phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase [EC:3.1.3.67]
hsa:64326 RFWD2, COP1, FLJ10416, RNF200; ring finger and WD repeat domain 2; K10143 E3 ubiquitin-protein ligase RFWD2 [EC:6.3.2.19]
hsa:7249 TSC2, FLJ43106, LAM, TSC4; tuberous sclerosis 2; K07207 tuberous sclerosis 2

hsa00592 alpha-Linolenic acid metabolism - Homo sapiens (human) (2)



hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04976 Bile secretion - Homo sapiens (human) (2)



hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide
hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1

hsa05330 Allograft rejection - Homo sapiens (human) (2)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (2)



hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa04740 Olfactory transduction - Homo sapiens (human) (2)





hsa:26188 OR1C1, HSTPCR27, OR1-42, OR1.5.10, ORL211, TPCR27; olfactory receptor, family 1, subfamily C, member 1; K04257 olfactory receptor
hsa:390538 OR4M2, OR15-3; olfactory receptor, family 4, subfamily M, member 2; K04257 olfactory receptor

hsa05144 Malaria - Homo sapiens (human) (2)



hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
hsa:6383 SDC2, HSPG, HSPG1, SYND2; syndecan 2; K06257 syndecan

hsa00640 Propanoate metabolism - Homo sapiens (human) (2)



hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]
hsa:8801 SUCLG2, GBETA; succinate-CoA ligase, GDP-forming, beta subunit (EC:6.2.1.4); K01900 succinyl-CoA synthetase beta subunit [EC:6.2.1.4 6.2.1.5]

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (2)



hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2903 GRIN2A, NMDAR2A, NR2A; glutamate receptor, ionotropic, N-methyl D-aspartate 2A; K05209 glutamate receptor, ionotropic, N-methyl-D-aspartate 2A

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (2)

hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa00260 Glycine, serine and threonine metabolism - Homo sapiens (human) (2)



hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:875 CBS, HIP4; cystathionine-beta-synthase (EC:4.2.1.22); K01697 cystathionine beta-synthase [EC:4.2.1.22]

hsa03013 RNA transport - Homo sapiens (human) (2)



hsa:1977 EIF4E, CBP, EIF4E1, EIF4EL1, EIF4F, MGC111573; eukaryotic translation initiation factor 4E; K03259 translation initiation factor eIF-4E
hsa:54913 RPP25, FLJ20374; ribonuclease P/MRP 25kDa subunit (EC:3.1.26.5); K14525 ribonucleases P/MRP protein subunit RPP25 [EC:3.1.26.5]

hsa04612 Antigen processing and presentation - Homo sapiens (human) (2)



hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa05143 African trypanosomiasis - Homo sapiens (human) (2)



hsa:5578 PRKCA, AAG6, MGC129900, MGC129901, PKC-alpha, PKCA, PRKACA; protein kinase C, alpha (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]
hsa:5579 PRKCB, MGC41878, PKC-beta, PKCB, PRKCB1, PRKCB2; protein kinase C, beta (EC:2.7.11.13); K02677 classical protein kinase C [EC:2.7.11.13]

hsa05323 Rheumatoid arthritis - Homo sapiens (human) (2)



hsa:2321 FLT1, FLT, VEGFR1; fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) (EC:2.7.10.1); K05096 FMS-like tyrosine kinase 1 [EC:2.7.10.1]
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa05219 Bladder cancer - Homo sapiens (human) (2)

hsa:1612 DAPK1, DAPK, DKFZp781I035; death-associated protein kinase 1 (EC:2.7.11.1); K08803 death-associated protein kinase [EC:2.7.11.1]
hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas

hsa04130 SNARE interactions in vesicular transport - Homo sapiens (human) (2)



hsa:2054 STX2, EPIM, EPM, MGC51014, STX2A, STX2B, STX2C; syntaxin 2; K08486 syntaxin 1B/2/3
hsa:8675 STX16, MGC90328, SYN16, hsyn16; syntaxin 16; K08489 syntaxin 16

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (2)



hsa:5071 PARK2, AR-JP, LPRS2, PDJ, PRKN; parkinson protein 2, E3 ubiquitin protein ligase (parkin); K04556 parkin [EC:6.3.2.19]
hsa:9695 EDEM1, EDEM, FLJ51559, FLJ51560, KIAA0212; ER degradation enhancer, mannosidase alpha-like 1; K10084 ER degradation enhancer, mannosidase alpha-like 1

hsa00480 Glutathione metabolism - Homo sapiens (human) (2)



hsa:2876 GPX1, GSHPX1, MGC14399, MGC88245; glutathione peroxidase 1 (EC:1.11.1.9); K00432 glutathione peroxidase [EC:1.11.1.9]
hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]

hsa04975 Fat digestion and absorption - Homo sapiens (human) (2)



hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa00591 Linoleic acid metabolism - Homo sapiens (human) (2)



hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04114 Oocyte meiosis - Homo sapiens (human) (2)

hsa:367 AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM; androgen receptor; K08557 androgen receptor
hsa:6196 RPS6KA2, HU-2, MAPKAPK1C, RSK, RSK3, S6K-alpha, S6K-alpha2, p90-RSK3, pp90RSK3; ribosomal protein S6 kinase, 90kDa, polypeptide 2 (EC:2.7.11.1); K04373 p90 ribosomal S6 kinase [EC:2.7.11.1]

hsa00982 Drug metabolism - cytochrome P450 - Homo sapiens (human) (2)



hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]
hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa05020 Prion diseases - Homo sapiens (human) (2)

hsa:2534 FYN, MGC45350, SLK, SYN; FYN oncogene related to SRC, FGR, YES (EC:2.7.10.2); K05703 proto-oncogene tyrosine-protein kinase Fyn [EC:2.7.10.2]
hsa:4685 NCAM2, MGC51008, NCAM21; neural cell adhesion molecule 2; K06491 neural cell adhesion molecule

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (2)



hsa:4214 MAP3K1, MAPKKK1, MEKK, MEKK1; mitogen-activated protein kinase kinase kinase 1 (EC:2.7.11.25); K04416 mitogen-activated protein kinase kinase kinase 1 [EC:2.7.11.25]
hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa05332 Graft-versus-host disease - Homo sapiens (human) (2)

hsa:3105 HLA-A, FLJ26655, HLAA; major histocompatibility complex, class I, A; K06751 major histocompatibility complex, class I
hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa03320 PPAR signaling pathway - Homo sapiens (human) (2)



hsa:2171 FABP5, E-FABP, EFABP, PA-FABP, PAFABP; fatty acid binding protein 5 (psoriasis-associated); K08754 fatty acid-binding protein 5, epidermal
hsa:2173 FABP7, B-FABP, BLBP, DKFZp547J2313, FABPB, MRG; fatty acid binding protein 7, brain; K08756 fatty acid-binding protein 7, brain

hsa00565 Ether lipid metabolism - Homo sapiens (human) (2)



hsa:5321 PLA2G4A, MGC126350, PLA2G4, cPLA2-alpha; phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]
hsa:8398 PLA2G6, CaI-PLA2, GVI, INAD1, IPLA2-VIA, NBIA2A, NBIA2B, PARK14, PLA2, PNPLA9, iPLA2; phospholipase A2, group VI (cytosolic, calcium-independent) (EC:3.1.1.4); K01047 phospholipase A2 [EC:3.1.1.4]

hsa04950 Maturity onset diabetes of the young - Homo sapiens (human) (2)

hsa:4825 NKX6-1, NKX6.1, NKX6A; NK6 homeobox 1; K08030 homeobox protein Nkx-6.1
hsa:6928 HNF1B, FJHN, HNF1beta, HNF2, HPC11, LF-B3, LFB3, MODY5, TCF2, VHNF1; HNF1 homeobox B; K08034 transcription factor 2, hepatocyte nuclear factor 1-beta

hsa00350 Tyrosine metabolism - Homo sapiens (human) (2)



hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]
hsa:7054 TH, DYT14, DYT5b, TYH; tyrosine hydroxylase (EC:1.14.16.2); K00501 tyrosine 3-monooxygenase [EC:1.14.16.2]

hsa00140 Steroid hormone biosynthesis - Homo sapiens (human) (2)



hsa:1584 CYP11B1, CPN1, CYP11B, DKFZp686B05283, FHI, FLJ36771, P450C11; cytochrome P450, family 11, subfamily B, polypeptide 1 (EC:1.14.15.4); K00497 cytochrome P450, family 11, subfamily B1 (steroid 11beta-monooxygenase) [EC:1.14.15.4]
hsa:3290 HSD11B1, 11-DH, 11-beta-HSD1, HDL, HSD11, HSD11B, HSD11L, MGC13539, SDR26C1; hydroxysteroid (11-beta) dehydrogenase 1 (EC:1.1.1.146); K00071 11beta-hydroxysteroid dehydrogenase [EC:1.1.1.146]

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (2)


hsa:3265 HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1; v-Ha-ras Harvey rat sarcoma viral oncogene homolog; K02833 GTPase HRas
hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (2)


hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II
hsa:721 C4B, C4B1, C4B12, C4B2, C4B3, C4B5, C4F, CH, CO4, CPAMD3, FLJ60561, MGC164979; complement component 4B (Chido blood group); K03989 complement component 4

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (2)

hsa:3953 LEPR, CD295, DKFZp686B1731, OBR; leptin receptor; K05062 leptin receptor
hsa:8660 IRS2, IRS-2; insulin receptor substrate 2; K07187 insulin receptor substrate

hsa04614 Renin-angiotensin system - Homo sapiens (human) (1)

hsa:186 AGTR2, AT2, ATGR2, MRX88; angiotensin II receptor, type 2; K04167 angiotensin II receptor type 2

hsa00240 Pyrimidine metabolism - Homo sapiens (human) (1)

hsa:1806 DPYD, DHP, DHPDHASE, DPD, MGC132008, MGC70799; dihydropyrimidine dehydrogenase (EC:1.3.1.2); K00207 dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]

hsa03008 Ribosome biogenesis in eukaryotes - Homo sapiens (human) (1)

hsa:54913 RPP25, FLJ20374; ribonuclease P/MRP 25kDa subunit (EC:3.1.26.5); K14525 ribonucleases P/MRP protein subunit RPP25 [EC:3.1.26.5]

hsa00670 One carbon pool by folate - Homo sapiens (human) (1)

hsa:4522 MTHFD1, MTHFC, MTHFD; methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (EC:1.5.1.5 6.3.4.3 3.5.4.9); K00288 methylenetetrahydrofolate dehydrogenase (NADP+) / methenyltetrahydrofolate cyclohydrolase / formyltetrahydrofolate synthetase [EC:1.5.1.5 3.5.4.9 6.3.4.3]

hsa00340 Histidine metabolism - Homo sapiens (human) (1)

hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa00983 Drug metabolism - other enzymes - Homo sapiens (human) (1)

hsa:1806 DPYD, DHP, DHPDHASE, DPD, MGC132008, MGC70799; dihydropyrimidine dehydrogenase (EC:1.3.1.2); K00207 dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]

hsa00360 Phenylalanine metabolism - Homo sapiens (human) (1)

hsa:4128 MAOA; monoamine oxidase A (EC:1.4.3.4); K00274 monoamine oxidase [EC:1.4.3.4]

hsa00430 Taurine and hypotaurine metabolism - Homo sapiens (human) (1)

hsa:2571 GAD1, FLJ45882, GAD, SCP; glutamate decarboxylase 1 (brain, 67kDa) (EC:4.1.1.15); K01580 glutamate decarboxylase [EC:4.1.1.15]

hsa04340 Hedgehog signaling pathway - Homo sapiens (human) (1)

hsa:7472 WNT2, INT1L1, IRP; wingless-type MMTV integration site family member 2; K00182 wingless-type MMTV integration site family, member 2

hsa04962 Vasopressin-regulated water reabsorption - Homo sapiens (human) (1)

hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide

hsa00620 Pyruvate metabolism - Homo sapiens (human) (1)

hsa:2739 GLO1, GLOD1, GLYI; glyoxalase I (EC:4.4.1.5); K01759 lactoylglutathione lyase [EC:4.4.1.5]

hsa00280 Valine, leucine and isoleucine degradation - Homo sapiens (human) (1)

hsa:18 ABAT, FLJ17813, FLJ30272, GABA-AT, GABAT, NPD009; 4-aminobutyrate aminotransferase (EC:2.6.1.19 2.6.1.22); K13524 4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase [EC:2.6.1.19 2.6.1.22]

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (1)

hsa:4233 MET, AUTS9, HGFR, RCCP2, c-Met; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1); K05099 proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]

hsa00534 Glycosaminoglycan biosynthesis - heparan sulfate - Homo sapiens (human) (1)

hsa:222537 HS3ST5, 3-OST-5, 3OST5, HS3OST5, NBLA04021; heparan sulfate (glucosamine) 3-O-sulfotransferase 5 (EC:2.8.2.23); K08104 [heparan sulfate]-glucosamine 3-sulfotransferase 5 [EC:2.8.2.23]

hsa00020 Citrate cycle (TCA cycle) - Homo sapiens (human) (1)

hsa:8801 SUCLG2, GBETA; succinate-CoA ligase, GDP-forming, beta subunit (EC:6.2.1.4); K01900 succinyl-CoA synthetase beta subunit [EC:6.2.1.4 6.2.1.5]

hsa04142 Lysosome - Homo sapiens (human) (1)

hsa:950 SCARB2, AMRF, CD36L2, HLGP85, LIMPII, SR-BII; scavenger receptor class B, member 2; K12384 lysosome membrane protein 2

hsa00770 Pantothenate and CoA biosynthesis - Homo sapiens (human) (1)

hsa:1806 DPYD, DHP, DHPDHASE, DPD, MGC132008, MGC70799; dihydropyrimidine dehydrogenase (EC:1.3.1.2); K00207 dihydropyrimidine dehydrogenase (NADP+) [EC:1.3.1.2]

hsa03010 Ribosome - Homo sapiens (human) (1)

hsa:6134 RPL10, DKFZp686J1851, DXS648, DXS648E, FLJ23544, FLJ27072, NOV, QM; ribosomal protein L10; K02866 large subunit ribosomal protein L10e

hsa00760 Nicotinate and nicotinamide metabolism - Homo sapiens (human) (1)

hsa:952 CD38, T10; CD38 molecule (EC:3.2.2.5); K01242 NAD+ nucleosidase [EC:3.2.2.5]

hsa00270 Cysteine and methionine metabolism - Homo sapiens (human) (1)

hsa:875 CBS, HIP4; cystathionine-beta-synthase (EC:4.2.1.22); K01697 cystathionine beta-synthase [EC:4.2.1.22]

hsa04974 Protein digestion and absorption - Homo sapiens (human) (1)

hsa:6505 SLC1A1, EAAC1, EAAT3; solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1; K05612 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1

hsa00512 Mucin type O-Glycan biosynthesis - Homo sapiens (human) (1)

hsa:114805 GALNT13, FLJ16031, FLJ41157, GalNAc-T13, H_NH0187G20.1, KIAA1918, MGC119459, MGC119461, WUGSC:H_NH0187G20.1; UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13) (EC:2.4.1.41); K00710 polypeptide N-acetylgalactosaminyltransferase [EC:2.4.1.41]

hsa03060 Protein export - Homo sapiens (human) (1)

hsa:83943 IMMP2L, IMP2, IMP2-LIKE; IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae); K09648 mitochondrial inner membrane protease subunit 2 [EC:3.4.99.-]

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (1)

hsa:6885 MAP3K7, MEKK7, TAK1, TGF1a; mitogen-activated protein kinase kinase kinase 7 (EC:2.7.11.25); K04427 mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]

hsa05340 Primary immunodeficiency - Homo sapiens (human) (1)

hsa:100 ADA; adenosine deaminase (EC:3.5.4.4); K01488 adenosine deaminase [EC:3.5.4.4]

hsa00514 Other types of O-glycan biosynthesis - Homo sapiens (human) (1)

hsa:10690 FUT9, Fuc-TIX; fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (EC:2.4.1.152); K03663 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase [EC:2.4.1.152]

hsa03420 Nucleotide excision repair - Homo sapiens (human) (1)

hsa:7508 XPC, RAD4, XP3, XPCC; xeroderma pigmentosum, complementation group C; K10838 xeroderma pigmentosum group C-complementing protein

hsa05310 Asthma - Homo sapiens (human) (1)

hsa:3123 HLA-DRB1, DRB1, DRw10, FLJ75017, FLJ76359, HLA-DR1B, HLA-DRB, HLA-DRB1*, SS1; major histocompatibility complex, class II, DR beta 1; K06752 major histocompatibility complex, class II

hsa04742 Taste transduction - Homo sapiens (human) (1)

hsa:2778 GNAS, AHO, C20orf45, GNAS1, GPSA, GSA, GSP, MGC33735, NESP, PHP1A, PHP1B, PHP1C, POH; GNAS complex locus; K04632 guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide

hsa00910 Nitrogen metabolism - Homo sapiens (human) (1)

hsa:765 CA6, CA-VI, GUSTIN, MGC21256; carbonic anhydrase VI (EC:4.2.1.1); K01672 carbonic anhydrase [EC:4.2.1.1]

hsa04146 Peroxisome - Homo sapiens (human) (1)

hsa:4843 NOS2, HEP-NOS, INOS, NOS, NOS2A; nitric oxide synthase 2, inducible (EC:1.14.13.39); K13241 nitric-oxide synthase, inducible [EC:1.14.13.39]

hsa03015 mRNA surveillance pathway - Homo sapiens (human) (1)

hsa:5521 PPP2R2B, B55BETA, FLJ95686, MGC24888, PP2AB55BETA, PP2ABBETA, PP2APR55B, PP2APR55BETA, PR2AB55BETA, PR2ABBETA, PR2APR55BETA, PR52B, PR55-BETA, PR55BETA, SCA12; protein phosphatase 2, regulatory subunit B, beta (EC:3.1.3.16); K04354 protein phosphatase 2 (formerly 2A), regulatory subunit B

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (1)

hsa:10690 FUT9, Fuc-TIX; fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (EC:2.4.1.152); K03663 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase [EC:2.4.1.152]

hsa03410 Base excision repair - Homo sapiens (human) (1)

hsa:8930 MBD4, MED1; methyl-CpG binding domain protein 4; K10801 methyl-CpG-binding domain protein 4 [EC:3.2.2.-]

hsa02010 ABC transporters - Homo sapiens (human) (1)

hsa:5243 ABCB1, ABC20, CD243, CLCS, GP170, MDR1, MGC163296, P-GP, PGY1; ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44); K05658 ATP-binding cassette, subfamily B (MDR/TAP), member 1

hsa00603 Glycosphingolipid biosynthesis - globo series - Homo sapiens (human) (1)

hsa:10690 FUT9, Fuc-TIX; fucosyltransferase 9 (alpha (1,3) fucosyltransferase) (EC:2.4.1.152); K03663 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase [EC:2.4.1.152]

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (1)

hsa:4698 NDUFA5, B13, CI-13KD-B, CI-13kB, DKFZp781K1356, FLJ12147, NUFM, UQOR13; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5, 13kDa (EC:1.6.5.3 1.6.99.3); K03949 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 5 [EC:1.6.5.3 1.6.99.3]

hsa05212 Pancreatic cancer - Homo sapiens (human) (1)

hsa:5294 PIK3CG, PI3CG, PI3K, PI3Kgamma, PIK3; phosphoinositide-3-kinase, catalytic, gamma polypeptide (EC:2.7.1.153); K00922 phosphatidylinositol-4,5-bisphosphate 3-kinase [EC:2.7.1.153]

hsa00100 Steroid biosynthesis - Homo sapiens (human) (1)

hsa:1717 DHCR7, SLOS; 7-dehydrocholesterol reductase (EC:1.3.1.21); K00213 7-dehydrocholesterol reductase [EC:1.3.1.21]

hsa00980 Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) (1)

hsa:2944 GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MGC26563, MU, MU-1; glutathione S-transferase mu 1 (EC:2.5.1.18); K00799 glutathione S-transferase [EC:2.5.1.18]

hsa00561 Glycerolipid metabolism - Homo sapiens (human) (1)

hsa:1608 DGKG, DAGK3, DGK-GAMMA, MGC104993, MGC133330; diacylglycerol kinase, gamma 90kDa (EC:2.7.1.107); K00901 diacylglycerol kinase [EC:2.7.1.107]